FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
V-Sciences Investments Pte Ltd
   2. Issuer Name and Ticker or Trading Symbol
VICAL INC [VICL] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director __X__ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last)
(First)
(Middle)
60B ORCHARD ROAD #06-18, TOWER 2, THE ATRIUM@ORCHARD		 3. Date of Earliest Transaction (Month/Day/Year)
05/07/2009
(Street)

SINGAPORE, U0 238891		 4. If Amendment, Date Original Filed(Month/Day/Year)
 6. Individual or Joint/Group Filing(Check Applicable Line)
___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)		 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)		 4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		 5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)		 6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)		 7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Shares 05/07/2009   S   205,260 D $ 2.3626 (1) 4,452,409 D (2)  
Common Shares 05/08/2009   S   129,600 D $ 2.3842 (3) 4,322,809 D (2)  

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)		 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)		 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)		 6. Date Exercisable and Expiration Date
(Month/Day/Year)		 7. Title and Amount of Underlying Securities
(Instr. 3 and 4)		 8. Price of Derivative Security
(Instr. 5)		 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)		 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)		 11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
V-Sciences Investments Pte Ltd
60B ORCHARD ROAD #06-18, TOWER 2
THE ATRIUM@ORCHARD
SINGAPORE, U0 238891		     X    
Temasek Life Sciences Private LTD
60B ORCHARD ROAD #06-18, TOWER 2
THE ATRIUM@ORCHARD
SINGAPORE, U0 238891		     X    
Fullerton Management Pte Ltd
60B ORCHARD ROAD #06-18, TOWER 2
THE ATRIUM@ORCHARD
SINGAPORE, U0 238891		     X    
TEMASEK HOLDINGS (PRIVATE) LTD
60B ORCHARD ROAD #06-18, TOWER 2
THE ATRIUM@ORCHARD
SINGAPORE, U0 238891		     X    

Signatures

 /s/ Chong Kwang Cheong Robert, Director, V-Sciences Investments Pte Ltd   05/11/2009
**Signature of Reporting Person Date
 /s/ Cheo Hock Kuan, Director, Temasek Life Sciences Private Limited   05/11/2009
**Signature of Reporting Person Date
 /s/ Lena Chia Yue Joo, Director, Fullerton Management Pte Ltd   05/11/2009
**Signature of Reporting Person Date
 /s/ Lena Chia Yue Joo, Managing Director, Legal & Regulations, Temasek Holdings (Private) Limited   05/11/2009
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Represents the weighted average price of 636 different transactions. Actual sale prices ranged from $2.17 to $2.60 per share. The reporting person will provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission (the "Staff"), upon request, information regarding the number of shares of common stock, $0.01 par value per share, which are the subject of this filing (the "Shares"), sold at each price within the range.
(2) Temasek Holdings (Private) Limited, is the parent of Fullerton Management Pte Ltd, which is the parent of Temasek Life Sciences Private Limited, which is the parent of V-Sciences Investments Pte Ltd (the designated filer), which directly owns the Shares. Because of the foregoing relationships, the direct and indirect parents of V-Sciences Investments Pte Ltd may be deemed to beneficially own the Shares.
(3) Represents the weighted average price of 431 different transactions. Actual sale prices ranged from $2.32 to $2.57 per share. The reporting person will provide to the issuer, any shareholder of the issuer, or the Staff, upon request, information regarding the number of Shares sold at each price within the range.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.